4.7 Article

Vimentin regulates peripheral nerve myelination

Journal

DEVELOPMENT
Volume 139, Issue 7, Pages 1359-1367

Publisher

COMPANY OF BIOLOGISTS LTD
DOI: 10.1242/dev.072371

Keywords

Myelination; Cytoskeleton; Neuregulin 1 type III; TACE; Mouse

Funding

  1. Telethon Italy Foundation [GGP08037, GPP10007]
  2. Association Francaise contre les Myopathies (AFM)
  3. ERA-Net for research programs on rare diseases (E-rare)
  4. Telethon Career Award

Ask authors/readers for more resources

Myelination is a complex process that requires coordinated Schwann cell-axon interactions during development and regeneration. Positive and negative regulators of myelination have been recently described, and can belong either to Schwann cells or neurons. Vimentin is a fibrous component present in both Schwann cell and neuron cytoskeleton, the expression of which is timely and spatially regulated during development and regeneration. We now report that vimentin negatively regulates myelination, as loss of vimentin results in peripheral nerve hypermyelination, owing to increased myelin thickness in vivo, in transgenic mice and in vitro in a myelinating co-culture system. We also show that this is due to a neuron-autonomous increase in the levels of axonal neuregulin 1 (NRG1) type III. Accordingly, genetic reduction of NRG1 type III in vimentin-null mice rescues hypermyelination. Finally, we demonstrate that vimentin acts synergistically with TACE, a negative regulator of NRG1 type III activity, as shown by hypermyelination of double Vim/Tace heterozygous mice. Our results reveal a novel role for the intermediate filament vimentin in myelination, and indicate vimentin as a regulator of NRG1 type III function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available